Virtual Medicinal Product (VMP) - Bevacizumab 3.75mg/0.15ml solution for injection pre-filled syringes
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Bevacizumab 3.75mg/0.15ml solution for injection pre-filled syringes | Start Date 23-10-2024 | End Date |
| Abbreviated Name | Abbreviated Name Bevacizumab 3.75mg/0.15ml inj pre-filled syringes | Start Date 23-10-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.15
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Caution - AMP level prescribing advised
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravitreal
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intravitreal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- S01LA08
| Code | Start Date | End Date |
|---|---|---|
| 44007511000001101 | 23-10-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Bevacizumab | Based on Ingredient Substance | 25 mg | 1 ml |
Name
Bevacizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
1
Parent Products
-
VTMBevacizumab
-
VMP(Current) Bevacizumab 3.75mg/0.15ml solution f...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 pre-filled disposable injection |